Keyphrases
Coronary Artery Disease
96%
Cardiovascular Disease
83%
Risk Factors
74%
Scottish
69%
Cardiovascular Risk
64%
Heart Health
61%
Cardiovascular Mortality
56%
Hazard Ratio
54%
MONICA
52%
Europe
43%
BiomarCaRE
41%
Heart Failure
38%
Event Rate
35%
Coronary Heart Disease Mortality
34%
Atrial Fibrillation
32%
Cardiovascular Risk Assessment
32%
Coronary Events
29%
All-cause Mortality
29%
Myocardial Infarction
28%
European Population
28%
Educational Classes
26%
Social Deprivation
24%
Population-based Cohort
24%
Confidence Interval
23%
Coronary Heart Disease Events
21%
Cardiovascular Risk Score
21%
European Cohort
20%
Diabetes
18%
Lipoproteins
17%
Population-based
17%
High-sensitivity C-reactive Protein (hs-CRP)
16%
Health Studies
16%
Survival Events
16%
Policy Model
16%
Blood Pressure
16%
Plasma Viscosity
16%
Allostatic Load
16%
Chronic Kidney Disease
16%
Mid-1990s
14%
High-sensitivity Cardiac Troponin
14%
Incident Cardiovascular Disease
14%
Meta-analysis
13%
Scotland
13%
Fibrinogen
13%
Systolic Blood Pressure
13%
European Regions
12%
Non-fatal
12%
Non-high-density Lipoprotein Cholesterol (non-HDL-C)
12%
Social Inequality
12%
Deprivation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
100%
Ischemic Heart Disease
95%
Cardiovascular Risk
61%
Biological Marker
36%
Atrial Fibrillation
32%
Cardiovascular Mortality
27%
Heart Infarction
26%
Cerebrovascular Accident
24%
Congestive Heart Failure
22%
Diseases
21%
All Cause Mortality
17%
Lipoprotein A
17%
C Reactive Protein
16%
Chronic Kidney Failure
16%
Troponin I
13%
High Density Lipoprotein Cholesterol
12%
Fibrinogen
11%
Troponin
10%
Cystatin C
10%
25 Hydroxyvitamin D
10%
Cohort Study
9%
Brain Natriuretic Peptide
8%
Creatinine
8%
Life Expectancy
8%
Actarit
8%
Egg Lecithin
8%
Peripheral Occlusive Artery Disease
8%
Case Fatality Rate
8%
Chronic Disease
8%
Chronic Obstructive Lung Disease
8%
Hemostatic Agent
8%
Melanoma
8%
Low Density Lipoprotein Cholesterol
8%
Apolipoprotein
8%
Diabetes Mellitus
7%
Protein C
6%
Inflammation
6%
Coronary Artery Atherosclerosis
5%
Von Willebrand Factor
5%
Blood Clotting Factor 8
5%
Tissue Plasminogen Activator
5%
D Dimer
5%
Medicine and Dentistry
Cardiovascular Disease
50%
Ischemic Heart Disease
43%
Congestive Heart Failure
36%
Cardiovascular Risk
34%
Biological Marker
32%
Hazard Ratio
30%
Cohort Analysis
27%
Apoplexy
24%
Cardiovascular System
20%
Myocardial Infarction
18%
Cardiovascular Mortality
18%
Diabetes
17%
Atrial Fibrillation
16%
Troponin I
13%
High Density Lipoprotein Cholesterol
12%
Cardiac Troponin
11%
Prevalence
11%
Family History
10%
Troponin
9%
Metabolite
9%
Meta-Analysis
9%
Case Fatality Rate
8%
Mediator
8%
Risk Stratification
8%
Diabetes Mellitus
8%
Seasonal Variation
8%
Life Expectancy
8%
Health Inequality
8%
Health Care Cost
8%
Actarit
8%
Social Isolation
8%
Egg Lecithin
8%
Chronic Kidney Disease
8%
Omega 6 Fatty Acid
8%
Pooled Analysis
8%
Linoleic Acid
8%
Left Ventricular Systolic Dysfunction
8%
Systolic Dysfunction
8%
Case-Control Study
8%
Proportional Hazards Model
8%
Brain Natriuretic Peptide
6%
Arachidonic Acid
6%
Amino Terminal Sequence
5%
Hospital Cost
5%
Cost-Effectiveness Analysis
5%
Lifespan
5%
Least Square Analysis
5%
Transient Ischemic Attack
5%
Peripheral Vascular Disease
5%
Brain Ischemia
5%
